LabCompass

Joo Mi Yi

Biochemistry, Genetics and Molecular Biology · Indiana University

OpenAlex
Epigenetics and DNA MethylationPancreatic and Hepatic Oncology ResearchCancer Genomics and DiagnosticsCancer Cells and MetastasisRNA modifications and cancer

Publications

159

Citations

3,082

Est. group size

—

Recurring co-author estimate

Active years

27

Publishing since 2001

Research summary
AI-generated

Joo Mi Yi studies how chemical changes to DNA and RNA (epigenetics), such as DNA methylation, influence the development and progression of cancers including colorectal, bladder, oral, and other tumors. A recurring goal is to identify molecular signatures that can serve as biomarkers for detecting cancer, predicting outcomes, or understanding drug and radiation resistance. Some work also extends to related conditions such as pulmonary fibrosis and cardiovascular disease.

Epigenetics and DNA methylationCancer biomarkers and diagnosticsNon-coding RNAs (microRNAs) in diseaseRadiation-induced molecular changesCancer cell signaling and drug resistance

Publication activity has been steady with a notable spike in 2023, and recent years show a lower, consistent output.

Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026

Publication cadence
Publications per year over the last 10 years — averaging 14.6/year recently
2017: 4 publications172018: 5 publications182019: 10 publications192020: 9 publications202021: 7 publications212022: 5 publications222023: 56 publications56232024: 6 publications242025: 5 publications252026: 1 publication26
Recent publications
Publishes in
  • Biomolecules & Therapeutics×4
  • Experimental & Molecular Medicine×3
  • Redox Biology×3
  • International Journal of Molecular Sciences×3
  • Signal Transduction and Targeted Therapy×3

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 11, 2026.

Claim or correct this profile